Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,081-1,092 of 4,306
Behavioral study icon
CompletedNCT05137158

iTBS on Negative Symptoms and Cognitive Function in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Changsha
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
China
Sponsor
Central South University
Condition
Schizophrenia
Drug study icon
CompletedNCT05110157

Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Phoenix
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.Over 18 Years
Countries
United States, Argentina, Bulgaria, ...
Sponsor
Neurocrine Biosciences
Condition
Schizophrenia
Drug study icon
CompletedNCT00145444

Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Study

This study is completed in Belgium and in the Netherlands. It focuses on Schizophrenia.

Multiple locations, including Antwerp
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 40 Years
Countries
Belgium, Netherlands
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia
Other study type icon
Active Not RecruitingNCT05968638

Ketogenic Diet in People With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Catonsville
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Drug study icon
WithdrawnNCT04054973

L-arginine Study for Persistent Symptoms of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Worcester
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Massachusetts, Worcester
Condition
Schizophrenia
Drug study icon
CompletedNCT01074073

Lithium Drug-Drug Interaction Study With Lurasidone HCl

This summary needs review. Please check the official study record and contact the research team for details.

In Culver City
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01614912

Long-term Extension Study of SM-13496 (Lurasidone HCl) in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Tokyo, Etc
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 74 Years
Countries
Japan, Malaysia, South Korea, ...
Sponsor
Sumitomo Pharma Co., Ltd.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.